V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220017772 | 220008772 | 1.5 | 63 | Curative (C) | 2017-05-10 | 2017-06-01 | Alemtuzumab cond (RI ALLO CAMP100) | Y | N | 220032980 | ALEMTUZUMAB |
| 220017773 | 220014712 | 1.58 | 63 | Curative (C) | 2016-05-23 | 2016-06-02 | Arsenic trioxide + Tretinoin | Y | N | 220032988 | ARSENIC TRIOXIDE + TRETINOIN |
| 220017774 | 220014713 | null | 74 | Curative (C) | null | 2015-04-30 | Carboplatin + Paclitaxel (3 weekly) | null | n | 220032991 | CARBOPLATIN + PACLITAXEL |
| 220017775 | 220014714 | 1.74 | 81 | Curative (C) | null | 2014-10-22 | IDARUBICIN | N | N | 220032996 | IDARUBICIN |
| 220017776 | 220014714 | null | 76.7 | Curative (C) | null | 2017-01-19 | CARBOPLATIN + GEMCITABINE | 01 | N | 220032996 | OXALIPLATIN + MDG |
| 220017777 | 220008781 | 1.71 | 47.75 | Curative (C) | 2016-09-14 | 2016-09-15 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220033003 | CLOFARABINE + CYTARABINE |
| 220017778 | 220008783 | 1.62 | 78.4 | Curative (C) | 2014-02-22 | 2014-02-23 | Carboplatin + Etoposide iv&po | Y | N | 220033010 | CARBOPLATIN + ETOPOSIDE |
| 220017779 | 220008785 | 1.5 | 83.45 | Curative (C) | 2017-08-03 | 2017-08-04 | IDARUBICIN | N | N | 220033011 | IDARUBICIN |
| 220017780 | 220020973 | 1.52 | 107.4 | Curative (C) | 2017-11-10 | 2017-11-10 | Carboplatin + Paclitaxel (3 weekly) | Y | N | 220033034 | CARBOPLATIN + PACLITAXEL |
| 220017781 | 220014718 | 1.62 | 51 | Curative (C) | 2013-07-18 | 2013-07-20 | PONATINIB | N | N | 220033039 | CISPLATIN + GEMCITABINE |
| 220017782 | 220019898 | 1.83 | 82.1 | Curative (C) | 2015-01-07 | 2015-01-12 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220033041 | PONATINIB |
| 220017783 | 220008791 | 1.78 | null | Curative (C) | 2015-12-04 | 2015-12-22 | Alemtuzumab cond (RI ALLO CAMP100) | 99 | N | 220033042 | ALEMTUZUMAB |
| 220017784 | 220008794 | null | null | Curative (C) | 2015-07-24 | 2015-08-24 | CARBOPLATIN + PACLITAXEL | N | N | 220033073 | CARBOPLATIN + PACLITAXEL |
| 220017785 | 220014722 | 1.83 | null | null | 2014-11-04 | 2014-11-29 | IDARUBICIN | N | N | 220033075 | IDARUBICIN |
| 220017786 | 220008797 | 1.71 | 64.4 | Disease modification (D) | 2016-12-12 | 2017-05-17 | PONATINIB | null | null | 220033081 | FLUDARABINE + MELPHALAN |
| 220017787 | 220008800 | 1.56 | 59.9 | Disease modification (D) | 2014-12-29 | 2015-01-04 | UKALL14- Intens/CNS Proph | N | N | 220033087 | GEMTUZUMAB OZOGAMICIN |
| 220017789 | 220018044 | null | 74 | Palliative (P) | 2014-06-20 | 2014-06-20 | ECX | N | N | 220033107 | PONATINIB |
| 220017790 | 220008807 | 1.81 | null | Palliative (P) | 2016-11-15 | 2016-11-15 | CISPLATIN + GEMCITABINE | N | N | 220033114 | OXALIPLATIN + MDG |
| 220017791 | 220008809 | 1.67 | 84.2 | Disease modification (D) | null | 2013-12-16 | Methotrexate + Folinic acid | null | null | 220033116 | IRINOTECAN + MDG |
| 220017792 | 220008810 | 1.74 | null | Curative (C) | 2013-05-01 | 2013-08-14 | Clofarabine + Cytarabine | N | N | 220033117 | GEMTUZUMAB OZOGAMICIN |
| 220017793 | 220008814 | 1.7 | 53 | Curative (C) | 2016-09-26 | 2016-10-03 | Paclitaxel 7 day | N | N | 220033122 | PACLITAXEL |
| 220017794 | 220008816 | null | null | Curative (C) | 2016-07-05 | 2016-07-24 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 220033123 | CARBOPLATIN + PACLITAXEL |
| 220017795 | 220008818 | 1.66 | 70.7 | Curative (C) | 2017-05-22 | 2017-05-26 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220033132 | PONATINIB |
| 220017796 | 220018048 | null | 86.4 | Palliative (P) | 2017-10-30 | 2017-11-30 | CARBOPLATIN + PACLITAXEL | N | N | 220033134 | CARBOPLATIN + PACLITAXEL |
| 220017798 | 220008824 | null | 79.9 | Curative (C) | 2016-01-23 | 2016-02-04 | Clofarabine + Cytarabine | N | N | 220033151 | DOCETAXEL |
| 220017799 | 220008825 | 1.73 | 84.4 | Curative (C) | 2017-05-10 | 2017-05-28 | Arsenic Triox + Tretinoin Ind W5-8 | N | N | 220033156 | ARSENIC TRIOXIDE + TRETINOIN |
| 220017800 | 220014733 | 1.85 | 84.2 | Curative (C) | 2016-08-28 | 2016-09-03 | GEMTUZUMAB OZOGAMICIN | N | N | 220033159 | METHOTREXATE |
| 220017801 | 220008831 | null | 102.6 | Curative (C) | 2014-05-11 | 2014-06-07 | Oxaliplatin + Modified de Gramont | 2 | N | 220033173 | GEMTUZUMAB OZOGAMICIN |
| 220017802 | 220008835 | 0 | 55.8 | Curative (C) | 2014-06-29 | 2014-07-05 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 220033208 | PACLITAXEL |
| 220017803 | 220008836 | 1.58 | 68 | Curative (C) | 2018-03-29 | 2018-03-30 | CARBOPLATIN + GEMCITABINE | N | N | 220033223 | CLOFARABINE + CYTARABINE |
| 220017806 | 220019903 | 1.57 | 54 | Disease modification (D) | null | 2016-04-17 | Paclitaxel 7 day | 02 | null | 220033238 | PACLITAXEL |
| 220017807 | 220008841 | 1.78 | 67.7 | Curative (C) | 2017-01-15 | 2017-04-23 | PACLITAXEL | 02 | N | 220033249 | PACLITAXEL |
| 220017808 | 220008843 | 1.75 | 75.45 | Curative (C) | 2016-06-26 | 2016-06-26 | Clofarabine + Cytarabine | 02 | null | 220033250 | CISPLATIN + GEMCITABINE |
| 220017809 | 220008849 | 1.85 | 74.75 | Palliative (P) | 2017-04-09 | 2017-04-09 | Cytarabine intrathecal | 2 | N | 220033259 | CYTARABINE INTRATHECAL |
| 220017810 | 220008852 | 1.66 | 64.8 | Curative (C) | 2016-04-29 | 2016-05-08 | Arsenic trioxide + Tretinoin | N | N | 220033260 | ARSENIC TRIOXIDE + TRETINOIN |
| 220017811 | 220008854 | 1.66 | 76.1 | Curative (C) | 2017-06-24 | 2017-07-24 | Fludarabine + Melphalan RIC Allo | N | N | 220033268 | FLUDARABINE + MELPHALAN |
| 220017812 | 220008856 | null | 70.9 | Curative (C) | 2018-01-27 | 2018-01-28 | GEMTUZUMAB OZOGAMICIN | 02 | N | 220033272 | CLOFARABINE + CYTARABINE |
| 220017813 | 220008857 | 1.67 | 89 | Curative (C) | 2013-07-04 | 2013-08-30 | GEMTUZUMAB OZOGAMICIN | 2 | N | 220033287 | PONATINIB |
| 220017814 | 220014746 | 1.76 | 78 | null | 2017-07-05 | 2017-07-05 | UKALL14- Ph 1 Induction | N | null | 220033287 | METHOTREXATE |
| 220017815 | 220008859 | 1.64 | 81.8 | Curative (C) | 2014-06-18 | 2014-06-22 | Mitox + Tretinoin Spanish Course 3 | 2 | N | 220033331 | MITOXANTRONE |
| 220017816 | 220008861 | 1.79 | null | Curative (C) | 2015-06-10 | 2015-08-21 | Alemtuzumab cond (RI ALLO CAMP100) | 2 | N | 220033334 | ALEMTUZUMAB |
| 220017817 | 220008863 | 1.64 | 78 | Curative (C) | 2017-12-31 | 2018-01-09 | CARBOPLATIN + ETOPOSIDE | 1 | N | 220033340 | CARBOPLATIN + ETOPOSIDE |
| 220017818 | 220008866 | 1.58 | 58.1 | Curative (C) | 2013-05-25 | 2013-06-14 | CARBOPLATIN + ETOPOSIDE | N | N | 220033348 | CARBOPLATIN + ETOPOSIDE |
| 220017819 | 220008866 | null | 69 | Curative (C) | 2017-01-29 | 2017-02-02 | Paclitaxel (2 or 3 weekly) | 02 | N | 220033348 | PACLITAXEL |
| 220017820 | 220008868 | null | 60 | Curative (C) | 2014-10-24 | 2014-10-25 | PONATINIB | N | null | 220033375 | FBC |
| 220017821 | 220008871 | null | 67 | null | 2016-02-04 | 2016-02-09 | Cytarabine intrathecal | N | N | 220033397 | CYTARABINE INTRATHECAL |
| 220017822 | 220014753 | 1.57 | 59.3 | Curative (C) | 2017-07-06 | 2017-07-12 | GEMTUZUMAB OZOGAMICIN | N | N | 220033414 | OXALIPLATIN + MDG |
| 220017823 | 220008874 | 1.51 | null | Curative (C) | 2015-07-31 | 2015-07-31 | Cytarabine intrathecal | 02 | N | 220033438 | CYTARABINE INTRATHECAL |
| 220017824 | 220008875 | 1.72 | 77.1 | Palliative (P) | 2014-11-17 | 2014-12-03 | GEMTUZUMAB OZOGAMICIN | null | null | 220033442 | FLUDARABINE + MELPHALAN |
| 220017825 | 220008877 | null | 103.8 | Curative (C) | 2014-12-22 | 2014-12-23 | Alemtuzumab cond (RI ALLO CAMP100) | Y | null | 220033445 | ALEMTUZUMAB |